Stockscreener 앱 받기
2.03
1.46%
-0.03
전일 마감가:
$2.06
열려 있는:
$2.04
하루 거래량:
35,786
Relative Volume:
0.15
시가총액:
$7.30M
수익:
-
순이익/손실:
$-15.47M
주가수익비율:
-4.06
EPS:
-0.5
순현금흐름:
$-13.51M
1주 성능:
-8.56%
1개월 성능:
+12.78%
6개월 성능:
+14.04%
1년 성능:
-65.02%
1일 변동 폭
$2.02
$2.07
1주일 범위
$2.02
$2.2899
52주 변동 폭
$1.30
$6.972
Nls Pharmaceutics Ltd Stock (NLSP) Company Profile
NLSP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NLSP
Nls Pharmaceutics Ltd
|
2.03 | 10.11M | 0 | -15.47M | -13.51M | -0.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.62 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.80 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
447.43 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
722.01 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
336.26 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Nls Pharmaceutics Ltd 주식(NLSP)의 최신 뉴스
Statistical indicators supporting NLS Pharmaceutics AG Equity Warrant’s strength2025 Market Sentiment & Real-Time Stock Price Movement Reports - Newser
Predicting NLS Pharmaceutics AG Equity Warrant trend using moving averagesQuarterly Profit Review & Free Expert Approved Momentum Trade Ideas - Newser
Analyzing drawdowns of NLS Pharmaceutics AG Equity Warrant with statistical toolsM&A Rumor & AI Forecasted Stock Moves - Newser
Using RSI to spot recovery in NLS Pharmaceutics AGPrice Action & AI Driven Stock Movement Reports - Newser
Real time pattern detection on NLS Pharmaceutics AG stock2025 Risk Factors & AI Enhanced Trade Execution Alerts - Newser
Signal strength of NLS Pharmaceutics AG Equity Warrant stock in tech scanners - Newser
How to use Fibonacci retracement on NLS Pharmaceutics AG Equity WarrantJuly 2025 Selloffs & Safe Entry Momentum Tips - Newser
When is the best time to exit NLS Pharmaceutics AG Equity WarrantJuly 2025 Breakouts & Expert-Curated Trade Recommendations - Newser
Tick level data insight on NLS Pharmaceutics AG volatilityFed Meeting & Proven Capital Preservation Methods - Newser
Short interest data insights for NLS Pharmaceutics AGQuarterly Profit Summary & Weekly High Return Forecasts - Newser
Price action breakdown for NLS Pharmaceutics AG Equity WarrantWeekly Volume Report & Expert Approved Momentum Trade Ideas - Newser
Key metrics from NLS Pharmaceutics AG Equity Warrant’s quarterly dataTrade Exit Report & Technical Entry and Exit Alerts - Newser
Using Bollinger Bands to evaluate NLS Pharmaceutics AG Equity WarrantTrade Signal Summary & Weekly High Return Stock Forecasts - Newser
NLS Pharmaceutics AG Equity Warrant stock momentum explainedJuly 2025 PostEarnings & Risk Managed Investment Entry Signals - Newser
Price momentum metrics for NLS Pharmaceutics AG Equity Warrant explainedJuly 2025 PostEarnings & AI Driven Stock Price Forecasts - Newser
Is NLS Pharmaceutics AG stock entering bullish territoryJuly 2025 Recap & AI Based Trade Execution Alerts - Newser
Visual analytics tools that track NLS Pharmaceutics AG Equity Warrant performanceTrade Analysis Summary & Safe Capital Growth Tips - Newser
NLS Pharmaceutics AG Equity Warrant’s volatility index tracking explainedJuly 2025 Setups & Fast Entry High Yield Tips - Newser
Watch for Trend Continuation in NLS Pharmaceutics AG Next Week2025 Market WrapUp & Safe Entry Zone Identification - beatles.ru
Using R and stats models for NLS Pharmaceutics AG forecastingWall Street Watch & Free Community Supported Trade Ideas - Newser
Using Ichimoku Cloud for NLS Pharmaceutics AG technicals2025 Institutional Moves & AI Powered Buy and Sell Recommendations - Newser
Top chart patterns to watch in NLS Pharmaceutics AG Equity WarrantTrade Risk Assessment & Low Volatility Stock Suggestions - Newser
Is NLS Pharmaceutics AG Equity Warrant stock entering bullish territory2025 Year in Review & Real-Time Stock Price Movement Reports - Newser
Comparing NLS Pharmaceutics AG Equity Warrant in custom built stock radarsPortfolio Value Report & Real-Time Market Trend Scan - Newser
Building trade automation scripts for NLS Pharmaceutics AG Equity WarrantMarket Growth Summary & Breakout Confirmation Alerts - Newser
NLS Pharmaceutics Extends Merger Deadline with Kadimastem to October 31, 2025. - AInvest
NLS Pharmaceutics Extends Merger Agreement with Kadimastem - TipRanks
Detecting support and resistance levels for NLS Pharmaceutics AGInsider Selling & Technical Entry and Exit Tips - Newser
Is NLS Pharmaceutics AG Equity Warrant a candidate for recovery playTrade Exit Summary & Safe Capital Growth Tips - Newser
Published on: 2025-08-29 16:48:48 - Newser
Best data tools to analyze NLS Pharmaceutics AG stockTrade Analysis Report & Daily Volume Surge Signals - Newser
Is this a good reentry point in NLS Pharmaceutics AG Equity WarrantWeekly Risk Report & Trade Opportunity Analysis Reports - Newser
Risk vs reward if holding onto NLS Pharmaceutics AGQuarterly Market Summary & Expert Approved Momentum Ideas - Newser
Nls Pharmaceutics Ltd (NLSP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.14%
1.34%
자본화:
|
볼륨(24시간):